Mohan Jitendra 4
4 · Astera Labs, Inc. · Filed Mar 19, 2026
Research Summary
AI-generated summary of this filing
Astera Labs (ALAB) CEO Mohan Jitendra Sells $20.7M Shares
What Happened
- Mohan Jitendra, CEO of Astera Labs, sold a total of 157,500 shares in open-market transactions on March 17, 2026, generating aggregate proceeds of approximately $20,723,774. The ten reported dispositions ranged in per-lot weighted-average prices from about $125.56 to $134.67 (individual lots and proceeds listed in the filing).
- These were sales (liquidity transactions), not purchases or option exercises. The filing indicates the sales occurred automatically under a Rule 10b5-1 trading plan adopted on December 1, 2025, which is a pre-arranged plan that can make such trades routine.
Key Details
- Transaction date: March 17, 2026 (Form 4 filed March 19, 2026 — appears timely).
- Total shares sold: 157,500; Total proceeds: $20,723,774.
- Per-lot details (from the filing): 8,754 @ $125.56 ($1,099,130); 5,746 @ $126.64 ($727,699); 3,624 @ $127.47 ($461,963); 7,907 @ $128.64 ($1,017,168); 11,120 @ $129.62 ($1,441,332); 13,880 @ $130.74 ($1,814,685); 22,766 @ $131.61 ($2,996,236); 43,289 @ $132.72 ($5,745,377); 22,309 @ $133.66 ($2,981,915); 18,105 @ $134.67 ($2,438,269).
- Several transactions report weighted-average prices with footnote ranges (the filer offers to provide per-price breakdowns on request — see footnotes F2–F12).
- Footnotes note that some shares referenced in the filing are held in various estate/living trusts (F3, F13–F17) and that the reporting person disclaims beneficial ownership of those trust-held shares except for any pecuniary interest.
- Filing timeliness: The report was filed two days after the trades (generally within the Section 16 reporting window), so no late-file indication was included.
Context
- Sales made pursuant to a Rule 10b5-1 plan are often automatic and pre-scheduled, which can reduce implication about the insider’s view of the company; sales alone are less informative than purchases about management sentiment.
- For retail investors, note this is insider selling for liquidity under a prearranged plan — not an option exercise or a gift. If you want the exact number of shares sold at each individual price within the ranges cited, the reporting person has offered to provide that breakdown upon request to the issuer, shareholders, or the SEC staff.
Insider Transaction Report
Form 4
Mohan Jitendra
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-03-17$125.56/sh−8,754$1,099,130→ 4,680,478 total(indirect: By Trust) - Sale
Common Stock
[F1][F4][F3]2026-03-17$126.64/sh−5,746$727,699→ 4,674,732 total(indirect: By Trust) - Sale
Common Stock
[F1][F5][F3]2026-03-17$127.47/sh−3,624$461,963→ 4,671,108 total(indirect: By Trust) - Sale
Common Stock
[F1][F6][F3]2026-03-17$128.64/sh−7,907$1,017,168→ 4,663,201 total(indirect: By Trust) - Sale
Common Stock
[F1][F7][F3]2026-03-17$129.62/sh−11,120$1,441,332→ 4,652,081 total(indirect: By Trust) - Sale
Common Stock
[F1][F8][F3]2026-03-17$130.74/sh−13,880$1,814,685→ 4,638,201 total(indirect: By Trust) - Sale
Common Stock
[F1][F9][F3]2026-03-17$131.61/sh−22,766$2,996,236→ 4,615,435 total(indirect: By Trust) - Sale
Common Stock
[F1][F10][F3]2026-03-17$132.72/sh−43,289$5,745,377→ 4,572,146 total(indirect: By Trust) - Sale
Common Stock
[F1][F11][F3]2026-03-17$133.66/sh−22,309$2,981,915→ 4,549,837 total(indirect: By Trust) - Sale
Common Stock
[F1][F12][F3]2026-03-17$134.67/sh−18,105$2,438,269→ 4,531,732 total(indirect: By Trust)
Holdings
- 699,999(indirect: By Trust)
Common Stock
[F13] - 700,000(indirect: By Trust)
Common Stock
[F14] - 700,000(indirect: By Trust)
Common Stock
[F15] - 450,001(indirect: By Trust)
Common Stock
[F16] - 450,001(indirect: By Trust)
Common Stock
[F17] - 1,452,739
Common Stock
Footnotes (17)
- [F1]The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.
- [F10]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.1750 to $133.1700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F11]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.1775 to $134.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F12]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.2000 to $135.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F13]These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F14]These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F15]These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F16]These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F17]These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $125.0700 to $126.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $126.0800 to $127.0600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $127.1100 to $128.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.1500 to $129.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $129.1600 to $130.1500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.1600 to $131.1500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.1600 to $132.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Philip Mazzara, Attorney-in-Fact|2026-03-19